Acorda challenges Actavis’s Ampyra generic

09-07-2014

US-based Acorda Therapeutics has sued Actavis for infringing four patents covering its multiple sclerosis (MS) drug Ampyra (dalfampridine).


Acorda, Actavis, Amprya, patent infringement, generics

LSIPR